img

Global Adalimumab Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Adalimumab Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis.
Adalimumab report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Adalimumab market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Adalimumab industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Adalimumab key manufacturers include AbbVie, Amgen, Sandoz, Boehringer Ingelheim, Mylan and Biogen, etc. AbbVie, Amgen, Sandoz are top 3 players and held % sales share in total in 2022.
Adalimumab can be divided into Adalimumab and Adalimumab Biosimilar, etc. Adalimumab is the mainstream product in the market, accounting for % sales share globally in 2022.
Adalimumab is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Adalimumab industry development. In 2022, global % sales of Adalimumab went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Adalimumab market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie
Amgen
Sandoz
Boehringer Ingelheim
Mylan
Biogen
Segment by Type
Adalimumab
Adalimumab Biosimilar

Segment by Application


Adults
Children

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Adalimumab market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Adalimumab, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Adalimumab industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Adalimumab in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Adalimumab introduction, etc. Adalimumab Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Adalimumab market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Adalimumab Market Overview
1.1 Adalimumab Product Overview
1.2 Adalimumab Market Segment by Type
1.2.1 Adalimumab
1.2.2 Adalimumab Biosimilar
1.3 Global Adalimumab Market Size by Type
1.3.1 Global Adalimumab Market Size Overview by Type (2018-2034)
1.3.2 Global Adalimumab Historic Market Size Review by Type (2018-2024)
1.3.3 Global Adalimumab Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Adalimumab Sales Breakdown by Type (2018-2024)
1.4.2 Europe Adalimumab Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Adalimumab Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Adalimumab Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Adalimumab Sales Breakdown by Type (2018-2024)
2 Global Adalimumab Market Competition by Company
2.1 Global Top Players by Adalimumab Sales (2018-2024)
2.2 Global Top Players by Adalimumab Revenue (2018-2024)
2.3 Global Top Players by Adalimumab Price (2018-2024)
2.4 Global Top Manufacturers Adalimumab Manufacturing Base Distribution, Sales Area, Product Type
2.5 Adalimumab Market Competitive Situation and Trends
2.5.1 Adalimumab Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Adalimumab Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adalimumab as of 2022)
2.7 Date of Key Manufacturers Enter into Adalimumab Market
2.8 Key Manufacturers Adalimumab Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Adalimumab Status and Outlook by Region
3.1 Global Adalimumab Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Adalimumab Historic Market Size by Region
3.2.1 Global Adalimumab Sales in Volume by Region (2018-2024)
3.2.2 Global Adalimumab Sales in Value by Region (2018-2024)
3.2.3 Global Adalimumab Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Adalimumab Forecasted Market Size by Region
3.3.1 Global Adalimumab Sales in Volume by Region (2024-2034)
3.3.2 Global Adalimumab Sales in Value by Region (2024-2034)
3.3.3 Global Adalimumab Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Adalimumab by Application
4.1 Adalimumab Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Adalimumab Market Size by Application
4.2.1 Global Adalimumab Market Size Overview by Application (2018-2034)
4.2.2 Global Adalimumab Historic Market Size Review by Application (2018-2024)
4.2.3 Global Adalimumab Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Adalimumab Sales Breakdown by Application (2018-2024)
4.3.2 Europe Adalimumab Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Adalimumab Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Adalimumab Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Adalimumab Sales Breakdown by Application (2018-2024)
5 North America Adalimumab by Country
5.1 North America Adalimumab Historic Market Size by Country
5.1.1 North America Adalimumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Adalimumab Sales in Volume by Country (2018-2024)
5.1.3 North America Adalimumab Sales in Value by Country (2018-2024)
5.2 North America Adalimumab Forecasted Market Size by Country
5.2.1 North America Adalimumab Sales in Volume by Country (2024-2034)
5.2.2 North America Adalimumab Sales in Value by Country (2024-2034)
6 Europe Adalimumab by Country
6.1 Europe Adalimumab Historic Market Size by Country
6.1.1 Europe Adalimumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Adalimumab Sales in Volume by Country (2018-2024)
6.1.3 Europe Adalimumab Sales in Value by Country (2018-2024)
6.2 Europe Adalimumab Forecasted Market Size by Country
6.2.1 Europe Adalimumab Sales in Volume by Country (2024-2034)
6.2.2 Europe Adalimumab Sales in Value by Country (2024-2034)
7 Asia-Pacific Adalimumab by Region
7.1 Asia-Pacific Adalimumab Historic Market Size by Region
7.1.1 Asia-Pacific Adalimumab Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Adalimumab Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Adalimumab Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Adalimumab Forecasted Market Size by Region
7.2.1 Asia-Pacific Adalimumab Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Adalimumab Sales in Value by Region (2024-2034)
8 Latin America Adalimumab by Country
8.1 Latin America Adalimumab Historic Market Size by Country
8.1.1 Latin America Adalimumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Adalimumab Sales in Volume by Country (2018-2024)
8.1.3 Latin America Adalimumab Sales in Value by Country (2018-2024)
8.2 Latin America Adalimumab Forecasted Market Size by Country
8.2.1 Latin America Adalimumab Sales in Volume by Country (2024-2034)
8.2.2 Latin America Adalimumab Sales in Value by Country (2024-2034)
9 Middle East and Africa Adalimumab by Country
9.1 Middle East and Africa Adalimumab Historic Market Size by Country
9.1.1 Middle East and Africa Adalimumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Adalimumab Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Adalimumab Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Adalimumab Forecasted Market Size by Country
9.2.1 Middle East and Africa Adalimumab Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Adalimumab Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Adalimumab Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AbbVie Adalimumab Products Offered
10.1.5 AbbVie Recent Development
10.2 Amgen
10.2.1 Amgen Company Information
10.2.2 Amgen Introduction and Business Overview
10.2.3 Amgen Adalimumab Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Amgen Adalimumab Products Offered
10.2.5 Amgen Recent Development
10.3 Sandoz
10.3.1 Sandoz Company Information
10.3.2 Sandoz Introduction and Business Overview
10.3.3 Sandoz Adalimumab Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sandoz Adalimumab Products Offered
10.3.5 Sandoz Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information
10.4.2 Boehringer Ingelheim Introduction and Business Overview
10.4.3 Boehringer Ingelheim Adalimumab Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Boehringer Ingelheim Adalimumab Products Offered
10.4.5 Boehringer Ingelheim Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Adalimumab Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Mylan Adalimumab Products Offered
10.5.5 Mylan Recent Development
10.6 Biogen
10.6.1 Biogen Company Information
10.6.2 Biogen Introduction and Business Overview
10.6.3 Biogen Adalimumab Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Biogen Adalimumab Products Offered
10.6.5 Biogen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Adalimumab Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Adalimumab Industrial Chain Analysis
11.4 Adalimumab Market Dynamics
11.4.1 Adalimumab Industry Trends
11.4.2 Adalimumab Market Drivers
11.4.3 Adalimumab Market Challenges
11.4.4 Adalimumab Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Adalimumab Distributors
12.3 Adalimumab Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Adalimumab
Table 2. Major Company of Adalimumab Biosimilar
Table 3. Global Adalimumab Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Adalimumab Sales by Type (2018-2024) & (K Units)
Table 5. Global Adalimumab Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Adalimumab Sales by Type (2018-2024) & (US& Million)
Table 7. Global Adalimumab Market Share in Value by Type (2018-2024)
Table 8. Global Adalimumab Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Adalimumab Sales by Type (2024-2034) & (K Units)
Table 10. Global Adalimumab Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Adalimumab Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Adalimumab Sales Market Share in Value by Type (2024-2034)
Table 13. Global Adalimumab Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Adalimumab Sales by Type (2018-2024) & (K Units)
Table 15. North America Adalimumab Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Adalimumab Sales (K Units) by Type (2018-2024)
Table 17. Europe Adalimumab Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Adalimumab Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Adalimumab Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Adalimumab Sales (K Units) by Type (2018-2024)
Table 21. Latin America Adalimumab Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Adalimumab Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Adalimumab Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Adalimumab Sales by Company (2018-2024) & (K Units)
Table 25. Global Adalimumab Sales Share by Company (2018-2024)
Table 26. Global Adalimumab Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Adalimumab Revenue Share by Company (2018-2024)
Table 28. Global Market Adalimumab Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Adalimumab Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Adalimumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adalimumab as of 2022)
Table 32. Date of Key Manufacturers Enter into Adalimumab Market
Table 33. Key Manufacturers Adalimumab Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Adalimumab Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Adalimumab Sales by Region (2018-2024) & (K Units)
Table 37. Global Adalimumab Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Adalimumab Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Adalimumab Sales Market Share in Value by Region (2018-2024)
Table 40. Global Adalimumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Adalimumab Sales by Region (2024-2034) & (K Units)
Table 42. Global Adalimumab Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Adalimumab Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Adalimumab Sales Market Share in Value by Region (2024-2034)
Table 45. Global Adalimumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Adalimumab Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Adalimumab Sales by Application (2018-2024) & (K Units)
Table 48. Global Adalimumab Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Adalimumab Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Adalimumab Sales Market Share in Value by Application (2018-2024)
Table 51. Global Adalimumab Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Adalimumab Sales by Application (2024-2034) & (K Units)
Table 53. Global Adalimumab Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Adalimumab Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Adalimumab Sales Market Share in Value by Application (2024-2034)
Table 56. Global Adalimumab Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Adalimumab Sales by Application (2018-2024) (K Units)
Table 58. North America Adalimumab Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Adalimumab Sales by Application (2018-2024) (K Units)
Table 60. Europe Adalimumab Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Adalimumab Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Adalimumab Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Adalimumab Sales by Application (2018-2024) (K Units)
Table 64. Latin America Adalimumab Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Adalimumab Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Adalimumab Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Adalimumab Sales by Country (2018-2024) & (K Units)
Table 68. North America Adalimumab Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Adalimumab Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Adalimumab Sales Market Share in Value by Country (2018-2024)
Table 71. North America Adalimumab Sales by Country (2024-2034) & (K Units)
Table 72. North America Adalimumab Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Adalimumab Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Adalimumab Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Adalimumab Sales by Country (2018-2024) & (K Units)
Table 76. Europe Adalimumab Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Adalimumab Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Adalimumab Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Adalimumab Sales by Country (2024-2034) & (K Units)
Table 80. Europe Adalimumab Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Adalimumab Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Adalimumab Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Adalimumab Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Adalimumab Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Adalimumab Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Adalimumab Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Adalimumab Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Adalimumab Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Adalimumab Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Adalimumab Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Adalimumab Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Adalimumab Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Adalimumab Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Adalimumab Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Adalimumab Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Adalimumab Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Adalimumab Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Adalimumab Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Adalimumab Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Adalimumab Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Adalimumab Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Adalimumab Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Adalimumab Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Adalimumab Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Adalimumab Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Adalimumab Sales Market Share in Value by Country (2024-2034)
Table 107. AbbVie Company Information
Table 108. AbbVie Introduction and Business Overview
Table 109. AbbVie Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. AbbVie Adalimumab Product
Table 111. AbbVie Recent Development
Table 112. Amgen Company Information
Table 113. Amgen Introduction and Business Overview
Table 114. Amgen Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Amgen Adalimumab Product
Table 116. Amgen Recent Development
Table 117. Sandoz Company Information
Table 118. Sandoz Introduction and Business Overview
Table 119. Sandoz Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Sandoz Adalimumab Product
Table 121. Sandoz Recent Development
Table 122. Boehringer Ingelheim Company Information
Table 123. Boehringer Ingelheim Introduction and Business Overview
Table 124. Boehringer Ingelheim Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Boehringer Ingelheim Adalimumab Product
Table 126. Boehringer Ingelheim Recent Development
Table 127. Mylan Company Information
Table 128. Mylan Introduction and Business Overview
Table 129. Mylan Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Mylan Adalimumab Product
Table 131. Mylan Recent Development
Table 132. Biogen Company Information
Table 133. Biogen Introduction and Business Overview
Table 134. Biogen Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Biogen Adalimumab Product
Table 136. Biogen Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Adalimumab Market Trends
Table 140. Adalimumab Market Drivers
Table 141. Adalimumab Market Challenges
Table 142. Adalimumab Market Restraints
Table 143. Adalimumab Distributors List
Table 144. Adalimumab Downstream Customers
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Adalimumab Product Picture
Figure 2. Global Adalimumab Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Adalimumab Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Adalimumab Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Adalimumab
Figure 6. Global Adalimumab Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Adalimumab Biosimilar
Figure 8. Global Adalimumab Biosimilar Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Adalimumab Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Adalimumab Sales Market Share by Type in 2022 & 2034
Figure 11. North America Adalimumab Sales Market Share in Volume by Type in 2022
Figure 12. North America Adalimumab Sales Market Share in Value by Type in 2022
Figure 13. Europe Adalimumab Sales Market Share in Volume by Type in 2022
Figure 14. Europe Adalimumab Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Adalimumab Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Adalimumab Sales Market Share in Value by Type in 2022
Figure 17. Latin America Adalimumab Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Adalimumab Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Adalimumab Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Adalimumab Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Adalimumab Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Adalimumab Revenue in 2022
Figure 23. Adalimumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Adults
Figure 25. Global Adults Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Children
Figure 27. Global Children Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Global Adalimumab Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Adalimumab Sales Market Share by Application in 2022 & 2034
Figure 30. North America Adalimumab Sales Market Share in Volume by Application in 2022
Figure 31. North America Adalimumab Sales Market Share in Value by Application in 2022
Figure 32. Europe Adalimumab Sales Market Share in Volume by Application in 2022
Figure 33. Europe Adalimumab Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Adalimumab Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Adalimumab Sales Market Share in Value by Application in 2022
Figure 36. Latin America Adalimumab Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Adalimumab Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Adalimumab Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Adalimumab Manufacturing Cost Structure
Figure 41. Adalimumab Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries